Cardio Diagnostics Holdings Inc.
Cardio Diagnostics Holdings Inc. (CDIO): 4 pipeline candidates · ~14 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
14.0 months
D/E 0.07 · 0% dilution
Lead: Approved
4 candidates
N/A
N/A
A transparent, data-derived signal for Cardio Diagnostics Holdings Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$6.0M
Cash
$7.1M
Quarterly Burn
$1.6M
Runway
14.0 mo
Revenue
$3K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| Epi+Gen CHD™ | — |
| HeartRisk™ | — |
| PrecisionCHD™ | — |
| tapscope 550 | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
13
Total value held
$406K
| Holder | Shares | Value |
|---|---|---|
| jane street group, llc | 81,283 | $159K |
| vanguard capital management llc | 40,310 | $79K |
| blackrock, inc. | 34,708 | $68K |
| geode capital management, llc | 32,177 | $63K |
| renaissance technologies llc | 15,348 | $30K |
| vanguard fiduciary trust co | 3,969 | $8K |
| wolverine asset management llc | 104 | $203 |
| morgan stanley | 100 | $195 |
| hrt financial lp | 62,482 | $121 |
| osaic holdings, inc. | 16 | $31 |
Showing top 10 of 13 institutional holders of Cardio Diagnostics Holdings Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Cardio Diagnostics Holdings Inc.'s pipeline?
Cardio Diagnostics Holdings Inc. (CDIO) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Cardio Diagnostics Holdings Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Cardio Diagnostics Holdings Inc. has approximately 14.0 months of cash runway.
What is Cardio Diagnostics Holdings Inc.'s market capitalization?
Cardio Diagnostics Holdings Inc.'s market capitalization is approximately $6.0M.
Who is the CEO of Cardio Diagnostics Holdings Inc.?
Dr. Meeshanthini V. Dogan Ph.D. is the chief executive officer of Cardio Diagnostics Holdings Inc. (CDIO).
Get the full picture on Cardio Diagnostics Holdings Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.